Literature DB >> 24112088

The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.

V Loizzi1, G Cormio, M Lorusso, D Latorre, M Falagario, P Demitri, D Scardigno, L E Selvaggi.   

Abstract

The aim of this study was to determine impact of lymph vascular space involvement (LVSI) on recurrence and survival in early stage of endometrial cancer. From 1991 through 2010, all endometrial cancer patients at University Hospital of Bari, Italy were identified. The Log-rank test and Kaplan-Meyer methods were used for time-to-event analysis to evaluate the effects of on lymph vascular space involvement recurrence rate and survival time. Of the 560 endometrial cancer patients, 525 underwent primary surgery. Of those, 399 had early stage disease. Three hundred and forty women were not found to have LVSI, whereas 59 were found to have lymph vascular space involvement. Forty-nine (12%) patients developed a recurrence and 20 of them showed lymph vascular space involvement. The statistical analysis demonstrated that LVSI was strongly associated with a poor survival (P < 0.0001). Lymph vascular space involvement is associated with a high risk of recurrence and poor overall survival in early stage of endometrial cancer; therefore, the clinical decision to decide whether or not a patient with early stage endometrial cancer should receive adjuvant therapy should be included the evaluation of lymph vascular space involvement.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  early stage endometrial cancer; lymph vascular space invasion; prognostic factors endometrial cancer

Mesh:

Year:  2013        PMID: 24112088     DOI: 10.1111/ecc.12115

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

Review 1.  Lymphovascular Space Invasion as a Risk Factor in Early Endometrial Cancer.

Authors:  Azmat H Sadozye; Rosie L Harrand; Nick S Reed
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

2.  Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.

Authors:  Salvatore Gizzo; Alberta Fabris; Pietro Litta; Carlo Saccardi
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.

Authors:  Yanfen Feng; Shumei Yan; Yuhua Huang; Qitao Huang; Fang Wang; Yiyan Lei
Journal:  BMC Cancer       Date:  2020-06-29       Impact factor: 4.430

4.  Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.

Authors:  Gitte Ørtoft; Lisa Lausten-Thomsen; Claus Høgdall; Estrid S Hansen; Margit Dueholm
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

5.  Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis.

Authors:  Yuan Cheng; Xiaobo Zhang; Zhiqi Wang; Jianliu Wang
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

6.  Surgical treatment of endometrial cancer in developing countries: reasons to consider systematic two-step surgical treatment.

Authors:  Cristina Anton; Giovanni Mastrantonio di Fávero; Christhardt Köhler; Filomena Marino Carvalho; Edmund Chada Baracat; Jesus Paula Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

7.  The Impact of Lymphovascular Space Invasion on Recurrence and Survival in Iranian Patients With Early Stage Endometrial Cancer.

Authors:  Setareh Akhavan; Azar Ahmadzadeh; Azamsadat Mousavi; Mitra Modares Gilany; Zohreh Kazemi; Fakher Rahim; Elham Shirali
Journal:  World J Oncol       Date:  2016-09-03

8.  Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Authors:  Anna L Beavis; Ting-Tai Yen; Rebecca L Stone; Stephanie L Wethington; Caitlin Carr; Ji Son; Laura Chambers; Chad M Michener; Stephanie Ricci; Wesley C Burkett; Debra L Richardson; Allison-Stuart Staley; Susie Ahn; Paola A Gehrig; Diogo Torres; Sean C Dowdy; Mackenzie W Sullivan; Susan C Modesitt; Catherine Watson; Ashely Veade; Jessie Ehrisman; Laura Havrilesky; Angeles Alvarez Secord; Amy Loreen; Kaitlyn Griffin; Amanda Jackson; Akila N Viswanathan; Leah R Jager; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2020-01-14       Impact factor: 5.482

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.